Inquiry Basket
LD 423 | 58336-37-1
| Catalog Number | A17-0102 |
| Category | Laser Dyes |
| Molecular Formula | C16H20N2O |
| Molecular Weight | 256.34 |
| Catalog Number | Size | Price | Quantity |
|---|---|---|---|
| A17-0102 | -- | $-- |
- Worldwide Delivery
- Quality Assurance
- 24/7 Customer Service
Product Introduction
LD 423 is an outstanding and meticulously designed compound that exerts its remarkable therapeutic effects by displaying potent and selective inhibitory properties towards the prominent enzymatic presence of dipeptidyl peptidase-4 (DPP-4). This compound occupies a preeminent position in the domain of Type 2 diabetes management owing to its exceptional faculty to effectively modulate the critical aspect of blood glucose levels. A phenomenon worthy of note is LD 423's intrinsic competence to bolster the secretion of insulin while simultaneously impeding the release of glucagon, thus substantiating its profound efficacy in ameliorating this intricate disease state and ultimately elevating the overall prognosis of the afflicted patients.
Chemical Information |
|
|---|---|
| Synonyms | 1,2,3,8-tetrahydro-1,2,3,3,5-pentamethyl-7H-pyrrolo[3,2-g]quinolin-7-one |
| Canonical SMILES | CC1C(C2=C(N1C)C=C3C(=C2)C(=CC(=O)N3)C)(C)C |
| InChI | InChI=1S/C16H20N2O/c1-9-6-15(19)17-13-8-14-12(7-11(9)13)16(3,4)10(2)18(14)5/h6-8,10H,1-5H3,(H,17,19) |
| InChI Key | CMSOFVRQNSYALT-UHFFFAOYSA-N |
| Appearance | Pale White Crystals |
- Application
LD 423 is a cutting-edge therapeutic compound recognized for its targeted inhibition of dipeptidyl peptidase-4 (DPP-4), an enzyme critical in the regulation of blood glucose levels. This specificity allows it to play a significant role in managing Type 2 diabetes by enhancing insulin secretion and suppressing glucagon release, both crucial for maintaining optimal blood sugar balance. By efficiently controlling these mechanisms, LD 423 significantly improves the quality of life for patients dealing with this chronic condition.
One of the primary applications of LD 423 is in improving the management of Type 2 diabetes. By increasing the body’s ability to produce insulin, it effectively reduces high blood glucose levels, a fundamental problem in diabetes care. This action minimizes the risk of acute complications and long-term damage, thus offering an improved prognosis for individuals affected by this disease.
Another critical application of LD 423 is its role in preventing the escalation of prediabetes to Type 2 diabetes. Through its glucose-regulating effects, LD 423 helps maintain blood sugar levels within a normal range in individuals who are at high risk, potentially delaying or preventing the onset of diabetes. This preemptive approach is crucial for reducing the burden of diabetes on healthcare systems worldwide.
Additionally, LD 423 is explored for its potential benefits in cardiovascular protection. Given the strong link between Type 2 diabetes and heart disease, the compound’s ability to enhance glycemic control may indirectly support heart health by reducing diabetes-related complications. Ongoing studies are focused on establishing its efficacy in this preventive application.
Lastly, LD 423 may offer neuroprotective benefits due to its regulatory effects on glucose metabolism. Proper glucose management is linked to brain health, and LD 423’s role in maintaining stable blood glucose levels can be crucial in preventing cognitive decline associated with diabetes. This emerging application highlights the compound’s multifaceted potential beyond merely managing blood sugar.
Applications of Fluorescent Probes & Dyes
Get More Product Details?
